FENC 8-K 2026-09-17
FENNEC PHARMACEUTICALS INC. (FENC) 8-K dated 2026-09-17 — accession 0001104659-26-108565.
FENNEC PHARMACEUTICALS INC. (FENC) is a biotechnology company listed on US.
FENNEC PHARMACEUTICALS INC. filed a 8-K on 2026-09-17. Accession 0001104659-26-108565.
This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported FENC revenue for 2025-12-31 was $44.6M. Net income was -$9.7M. Revenue was down 6.1% from 2024-12-31 to 2025-12-31. FENC currently screens at market cap $302.2M.
Not investment advice. The FENC SEC hub lists recent forms. The stock page is the research view.